Merck & Co., Inc.

6MK.F·Frankfurt·Healthcare
Compare
133.02+1.36 (+1.03%)today
As of Oct 22, 8:02 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close131.66
Open133.02
Day range—
52-week range71.60135.00
Off day high0.00%
Off 52-week high−1.47%
Volume470
Avg. volume (3M)493
Market cap328.18B
EPS (TTM)1.08
Forward P/E—
P/E ratio (TTM)123.17
Dividend yield2.35% (3.02)
Beta (5Y)0.22
Shares outstanding2.47B
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin4.77%

Against its peers

Compare in full ›
6MK.F AZN PFE NOT.DE GSK JNJ
Market cap 328.18B 268.97B 172.13B 263.25B 102.73B 645.95B
P/E (TTM) 123.2 25.9 39.7 24.4 16.2 40.7
Forward P/E — 15.3 10.5 — 10.4 23.1
Price/book 8.8 5.3 2.0 7.1 4.4 7.6
Dividend yield 2.35% 1.90% 5.76% 3.00% 3.63% 2.08%
1-year change +71.05% +0.99% +21.00% +21.21% +9.84% +33.93%
Today +1.03% +2.95% +1.17% +1.07% +2.51% +3.98%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Merck's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
AstraZeneca PLCAZN · Drug Manufacturers - General 268.97B 173.43 +2.95%
Pfizer Inc.PFE · Drug Manufacturers - GeneralOdds 172.13B 30.20 +1.17%
Novartis AGNOT.DE · Drug Manufacturers - General 263.25B 138.50 +1.07%
GSK plcGSK · Drug Manufacturers - General 102.73B 51.28 +2.51%
Johnson & JohnsonJNJ · Drug Manufacturers - General 645.95B 268.04 +3.98%
SanofiSNY · Drug Manufacturers - General 100.75B 42.05 +2.62%
Biogen Inc.BIIB · Drug Manufacturers - General 36.99B 250.35 +3.89%
Bayer AktiengesellschaftBAYN.F · Drug Manufacturers - General 43.36B 44.14 −1.10%

Other companies in Drug Manufacturers - General, closest in size first.

Company Mkt cap Price Today
Roche Holding AGROP.SW · Basel, Switzerland 312.41B 392.10 +0.03%
Novartis AGNVS · Basel, Switzerland 297.27B 156.40 +1.60%
AstraZeneca PLCAZN · Cambridge, United Kingdom 268.97B 173.43 +2.95%
Amgen Inc.AMGN · Thousand Oaks, CA 242.45B 448.45 +2.31%
AbbVie Inc.ABBV · North Chicago, IL 502.39B 284.30 −0.18%
Gilead Sciences, Inc.GILD · Foster City, CAOdds 193.87B 156.35 +1.81%
Novo Nordisk A/SNVO · Bagsvaerd, Denmark 174.94B 39.64 +1.48%
Pfizer Inc.PFE · New York, NYOdds 172.13B 30.20 +1.17%

The stocks whose daily moves over the past year went most closely with Merck's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
GSK plcGSK · Correlation 0.33 102.73B 51.28 +2.51%
Biogen Inc.BIIB · Correlation 0.32 36.99B 250.35 +3.89%
Johnson & JohnsonJNJ · Correlation 0.32 645.95B 268.04 +3.98%
AstraZeneca PLCAZN · Correlation 0.31 268.97B 173.43 +2.95%
Pfizer Inc.PFE · Correlation 0.30Odds 172.13B 30.20 +1.17%

What visitors to Merck's page also look at.

Company Mkt cap Price Today
COCA-COLA CO., THECCC3.F 362.96B 84.36 +2.25%
PROCTER & GAMBLE CO., THEPRG.F 326.52B 140.58 +0.19%
AbbVie Inc.4AB.F 448.85B 254.00 −1.01%
PFIZER INC.PFE.F 154.06B 27.03 +1.98%
Eli Lilly and CompanyLLY.F 1.05T 1,175.20 +4.00%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All 6MK.F news ›
pharmaphorum·

Merck buys Silence and its siRNA pipeline for $1.3bn

Merck KGaA has reached a deal to acquire UK-based Silence Therapeutics in ​an all-cash, $1.3 billion deal that will boost its presence in RNA-focused drugs and give it a late-stage drug candidate for rare disease polycythemia vera (PV).…

Seeking Alpha·Positive

Merck KGaA to buy Silence Therapeutics in all-cash deal

Merck KGaA to acquire Silence Therapeutics for $1.3B cash, a 130% premium, boosting siRNA pipeline and rare-disease focus. Merck KGaA (MKGAY) (MKGAF) has agreed to acquire Silence Therapeutics (SLN) in an all-cash deal with an enterprise…

TIKR.com·Positive

Better Dividend Stock: Merck vs. Bristol Myers Squibb

Pressmaster from Pressmaster and Ri_Ya from pixabay Merck (MRK) and Bristol Myers Squibb (BMY) both raised their 2026 sales outlooks this summer. That’s good news for income investors, since a growing business keeps a dividend growing. The…

medwatch.com·

Merck buys biotech Silence Therapeutics for USD 1.1bn

Senior Drug Product Filling Specialist Associate Market Access Director – International Markets Senior Drug Substance Scientist Head of Medical Affairs International Markets Chef for Kvalitet og Compliance Head of Clinical Operations…

From articles in the 4Search news index.

In the news

192mentions in 30 days
192with it in the headline
Positivesentiment

Mentioned with

Merck & Co., Inc.167Merck Kgaa141Pfizer134Life Sciences Innovation118Morgan Stanley115Merck & Co., Inc112Merck & CO102Buy Verona Pharma100

People in the coverage

Keytruda167Moderna121Rob Davis88Dean Y. LI80Mitch Edgeman58Kim Johansen57

Themes

Mrk164Pharmaceuticals124Equities100Healthcare81Biotechnology76Merck & Co.65Merck Kgaa65Pharma55

Most coverage from

  1. marketscreener.com35
  2. marketbeat.com24
  3. gurufocus.com10
  4. tradingview.com9
  5. theglobeandmail.com8

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.